BlueCrest Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,475	Closed	-$582K	–	621
2019 Q3	$582K	Buy	+7,475	New	+$582K	0.04%	241
2018 Q2	–	Sell	-82,085	Closed	-$2.52M	–	1872
2018 Q1	$2.52M	Buy	+82,085	New	+$2.52M	0.08%	239